Newsletter
Enabling Lower-Cost Prescribing at the Point-of-Care with Kyle Kiser, CEO at RxRevu

Outcomes Rocket

Enabling Lower-Cost Prescribing at the Point-of-Care with Kyle Kiser, CEO at RxRevu

October 21, 2021

Enabling Lower-Cost Prescribing at the Point-of-Care with Kyle Kiser, CEO at RxRevu

In this Outcomes Rocket Pharma episode, we are privileged to host Kyle Kiser, CEO at RxRevu. Kyle discusses how his company provides patient-specific, real-time insights into prescribing decisions, delivering patient, provider, and health plan benefits due to lower cost and improved adherence. He also shares what makes RxRevu stand out from other companies in the pharma space. Kyle shares his thoughts on some of the challenges he has seen in both the payer and provider sides, so make sure to tune in!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
How is Parkinson’s Disease Diagnosed? And How Is a Care Team Created? Parkinson’s disease can’t be diagnosed through a simple blood test or scan. After a referral from a primary care doctor, it often takes visits to a neurologist or movement disorder specialist before receiving a clinical diagnosis.